Raja Krishnamoorthi (D-IL)
Medicare Expansion and Lowering Costs Now Act
A Democratic bill with no cosponsors
Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
The Medicare Expansion and Lowering Costs Now Act allows people aged 50 to 64 to buy into Medicare. It creates a voluntary supplemental insurance program to cover deductibles and copayments for those already in Medicare parts A and B. The bill authorizes the Secretary to negotiate lower prices for covered part D drugs. It also establishes an Individual Market Reinsurance Fund to stabilize health insurance markets. Additionally, it increases eligibility for premium tax credits by removing the 400 percent poverty line cap.
Yes· 3 of 25
- Scored +9
Would people in middle age be better off under this?
Directly benefits individuals aged 50-64 by allowing early entry into Medicare.
- Scored +9
Would households on low incomes be better off under this?
Expands financial assistance and removes income caps for premium tax credits.
- Scored +9
Does this lower the price of prescription medicines?
Explicitly mandates the Secretary to negotiate lower prices for Part D drugs.
The opposite· 3 of 5
- Scored -3
Does this reduce what the federal government spends?
The bill increases spending through the Individual Market Reinsurance Fund and expanded tax credit eligibility.
- Scored -2
Does this put more money into Medicaid, the health coverage for people on low incomes?
Prohibits states from buying Medicaid beneficiaries into the new Medicare buy-in option.
- Scored -2
Does this leave more decisions to the states?
Prohibits states from using Medicaid funds to buy beneficiaries into the Medicare buy-in option.
Who it would affect, and how
Potential Positive Impacts for People
- Early Medicare Access: Individuals aged 50 to 64 who meet specific eligibility requirements can now enroll in Medicare, receiving the same benefits and protections as those 65 and older (Section 3(a)).
- Reduced Out-of-Pocket Costs: A new voluntary supplemental program will pay for deductibles, copayments, and other cost-sharing amounts, subject to a $100 annual deductible (Section 4(c)(1)).
- Lower Drug Prices: The Secretary is required to negotiate prices, discounts, and rebates with pharmaceutical manufacturers for covered part D drugs (Section 5(a)(1)).
- Financial Assistance: Enrollees in the buy-in option can receive financial assistance for coverage similar to the assistance provided through an Exchange (Section 3(g)(1)).
- Expanded Tax Credits: The removal of the 400 percent poverty line cap increases the number of people eligible for premium tax credits (Section 10(a)).
- Market Stabilization: The Individual Market Reinsurance Fund provides payments to insurers for high-cost individuals, which is intended to stabilize the individual health insurance market (Section 6(b)(1)).
Potential Negative Impacts for People
- Late Enrollment Penalties: Individuals who do not enroll in the direct supplemental insurance program during specified periods will face a monthly premium increase of 10 percent for each 12-month period they were eligible but not enrolled (Section 4(d)(2)(B)).
- Buy-In Costs: Individuals choosing the Medicare buy-in option must pay a monthly premium determined by the Secretary (Section 3(c)(1)).
- Medicaid Restrictions: States are prohibited from buying their Medicaid beneficiaries ages 50 to 64 into the Medicare buy-in option, and those eligible for a State plan are generally prohibited from this coverage (Section 3(h)(3)).
- Additional Drug Plan Costs: If an individual chooses a prescription drug plan with supplemental benefits or a more expensive plan, their monthly premium will increase (Section 3(c)(3)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would households on low incomes be better off under this? — Expands financial assistance and removes income caps for premium tax credits. Would people in middle age be better off under this? — Directly benefits individuals aged 50-64 by allowing early entry into Medicare. Would middle-income households be better off under this? — Expands eligibility for premium tax credits beyond the 400% poverty line. Would retired people be better off under this? — Reduces prescription drug costs and introduces a voluntary supplemental insurance option. Would people over 65 be better off under this? — Provides lower drug costs and a new supplemental insurance option for those 65+. Would people with disabilities be better off under this? — Reduces cost-sharing and expands access to Medicare for those with health needs. Would Black Americans be better off under this? — Increases access to affordable health insurance for lower-income populations. Would Hispanic Americans be better off under this? — Increases access to affordable health insurance for lower-income populations. Would Native Americans be better off under this? — Increases access to affordable health insurance for lower-income populations. Would Asian Americans be better off under this? — Increases access to affordable health insurance for lower-income populations. Would white Americans be better off under this? — Increases access to affordable health insurance for lower-income populations.
- Healthcare
- Does this make health care easier to get in general? — Provides a path to Medicare for 50-64 year olds and expands financial assistance for coverage. Does this lower the price of prescription medicines? — Explicitly mandates the Secretary to negotiate lower prices for Part D drugs. Does this strengthen the Affordable Care Act? — Expands premium tax credits and establishes a reinsurance fund to stabilize the individual market. Does this put more money into Medicare, the health coverage for people over 65? — Expands Medicare eligibility to individuals aged 50-64. Does this lower what people pay for private health insurance? — Reinsurance funds and risk corridors are designed to lower premiums by offsetting high-cost claims. Does this put more money into Medicaid, the health coverage for people on low incomes? — Prohibits states from buying Medicaid beneficiaries into the new Medicare buy-in option.
- Social Issues And Justice
- Is this likely to lift people out of poverty? — Reduces the financial burden of healthcare through expanded tax credits and Medicare access. Does this strengthen Social Security? — Expands the utility of the Medicare portion of the Social Security Act. Does this expand the rights of people with disabilities? — Provides expanded insurance options and reduced cost-sharing for people with chronic health needs. Does this narrow racial gaps in how people are treated? — Increases healthcare access for low-income populations who are disproportionately marginalized.
- Governance And Ideology
- Does this give the federal government more power? — Increases federal oversight of drug pricing and establishes new federal trust funds. Does this make what the government does easier for the public to see? — Requires semi-annual reports to Congress on drug price negotiations. Does this leave more decisions to the states? — Prohibits states from using Medicaid funds to buy beneficiaries into the Medicare buy-in option.
- Economy And Finance
- Does this cut taxes for middle-income families? — Removing the 400% poverty line cap for premium tax credits reduces the effective cost of healthcare for middle-class households. Does this give people more protection from unfair business practices? — Increases consumer access to affordable healthcare and stabilizes insurance markets. Is this likely to slow the rise in prices? — Negotiating lower prescription drug prices may contribute to lower healthcare inflation. Does this reduce what the federal government spends? — The bill increases spending through the Individual Market Reinsurance Fund and expanded tax credit eligibility. Does this make the government pay for what it commits to? — The bill creates new spending obligations and trust funds without specified offsets. Does this reduce what the federal government owes? — Expansion of Medicare eligibility and increased tax credits likely increase federal spending.
- 3/12/2026
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House